Creo Medical Group PLC LSE:CREO:

  • EXPECTS FY26 REVENUE GROWTH OF 50%-60% COMPARED TO FY25

  • EXPECT 15% REDUCTION IN ANNUAL OPERATING COSTS FROM FY25 CLOSING RUN RATE

  • Q1 FY26 REVENUE GROWS ABOUT 60% YEAR-ON-YEAR